Tag "CellPathfinder"

Revealing the pathophysiology of COVID19 infections: Yokogawa supports COVID19 research at the Charité in Berlin

The COVID19 pandemic is negatively impacting the health of humans, societies and the economy around the world. Researchers are desperately trying to better understand the viral cause as well as progression of the disease seeking for better treatments and ultimately a vaccine. Yokogawa assumes its social responsibility and starts new scientific collaborations to support the world’s fight against COVID19.

Read More

The Future of High Content Analysis is 3D

Yokogawa and InSphero combine the power of advanced HCA (High Content Analysis) platform with multicellular 3D models for drug discovery. By the way: There’s a free webinar on June 18th on the subject. Registration is possible at the end of the blog article.

Read More